These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration. Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466 [TBL] [Abstract][Full Text] [Related]
3. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. Jensen PS; Bhatara VS; Vitiello B; Hoagwood K; Feil M; Burke LB J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):557-65. PubMed ID: 10230187 [TBL] [Abstract][Full Text] [Related]
4. Mood stabilizers in children and adolescents. Ryan ND; Bhatara VS; Perel JM J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):529-36. PubMed ID: 10230184 [TBL] [Abstract][Full Text] [Related]
5. The future of pediatric psychopharmacology. Walkup JT; Cruz K; Kane S; Geller B Pediatr Clin North Am; 1998 Oct; 45(5):1265-78. PubMed ID: 9884685 [TBL] [Abstract][Full Text] [Related]
6. Ethical issues in psychopharmacology of children and adolescents. Koelch M; Schnoor K; Fegert JM Curr Opin Psychiatry; 2008 Nov; 21(6):598-605. PubMed ID: 18852568 [TBL] [Abstract][Full Text] [Related]
8. Changes in the practice of child and adolescent psychiatry: are our patients better served? Jellinek MS J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):115-7. PubMed ID: 9951208 [No Abstract] [Full Text] [Related]
9. The EU paediatric regulation: effects on paediatric psychopharmacology in Europe. Stoyanova-Beninska VV; Wohlfarth T; Isaac M; Kalverdijk LJ; van den Berg H; Gispen-de Wied C Eur Neuropsychopharmacol; 2011 Aug; 21(8):565-70. PubMed ID: 20621456 [TBL] [Abstract][Full Text] [Related]
10. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295 [TBL] [Abstract][Full Text] [Related]
11. Preface: Pediatric and adolescent psychopharmacology: the past, the present, and the future. Greydanus DE; Patel DR; Feucht C Pediatr Clin North Am; 2011 Feb; 58(1):xv-xxiv. PubMed ID: 21281843 [No Abstract] [Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. Review of safety assessment methods used in pediatric psychopharmacology. Greenhill LL; Vitiello B; Riddle MA; Fisher P; Shockey E; March JS; Levine J; Fried J; Abikoff H; Zito JM; McCracken JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Walkup JT; Capasso L; Rosengarten J J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):627-33. PubMed ID: 12921469 [TBL] [Abstract][Full Text] [Related]
14. Psychotherapy in controlled psychopharmacology trials. Does it matter if we ignore it? Koek RJ; Hejran RN; Mintz J Contemp Clin Trials; 2005 Jun; 26(3):338-48. PubMed ID: 15911468 [TBL] [Abstract][Full Text] [Related]
15. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology. Fava M J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583 [TBL] [Abstract][Full Text] [Related]
16. The growth of psychopharmacology in the 1990s: evidence-based practice or irrational exuberance. Rosenheck R Int J Law Psychiatry; 2005; 28(5):467-83. PubMed ID: 16126271 [TBL] [Abstract][Full Text] [Related]
17. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
18. Teaching evidence-based medicine pediatric psychopharmacology: integrating psychopharmacologic treatment into the broad spectrum of care. Chrisman AK; Enderlin HT; Landry KL; Colvin JS; DeJohn MR Child Adolesc Psychiatr Clin N Am; 2007 Jan; 16(1):165-81, x. PubMed ID: 17141123 [TBL] [Abstract][Full Text] [Related]
19. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. Deveaugh-Geiss J; March J; Shapiro M; Andreason PJ; Emslie G; Ford LM; Greenhill L; Murphy D; Prentice E; Roberts R; Silva S; Swanson JM; VAN Zwieten-Boot B; Vitiello B; Wagner KD; Mangum B J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):261-270. PubMed ID: 16540810 [TBL] [Abstract][Full Text] [Related]
20. How can we improve the assessment of safety in child and adolescent psychopharmacology? Vitiello B; Riddle MA; Greenhill LL; March JS; Levine J; Schachar RJ; Abikoff H; Zito JM; McCracken JT; Walkup JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Capasso L J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):634-41. PubMed ID: 12921470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]